Drug Shortage Report for PURINETHOL
| Report ID | 231946 |
| Drug Identification Number | 00004723 |
| Brand name | PURINETHOL |
| Common or Proper name | PURINETHOL 50MG TABLETS |
| Company Name | TEVA CANADA LIMITED |
| Market Status | MARKETED |
| Active Ingredient(s) | MERCAPTOPURINE |
| Strength(s) | 50MG |
| Dosage form(s) | TABLET |
| Route of administration | ORAL ORAL |
| Packaging size | 60 |
| ATC code | L01BB |
| ATC description | ANTIMETABOLITES |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | 2024-12-01 |
| Actual start date | 2024-12-18 |
| Estimated end date | 2026-03-31 |
| Actual end date | |
| Shortage status | Actual shortage |
| Updated date | 2024-12-19 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 30 NOVOPHARM COURT TORONTO, ONTARIO CANADA M1B 2K9 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v7 | 2024-12-19 | French | Compare |
| v6 | 2024-12-19 | English | Compare |
| v5 | 2024-12-13 | French | Compare |
| v4 | 2024-12-13 | English | Compare |
| v3 | 2024-12-02 | English | Compare |
| v2 | 2024-07-03 | French | Compare |
| v1 | 2024-07-03 | English | Compare |
Showing 1 to 7 of 7